Akebia Therapeutics dba Keryx Biopharmaceutials, Inc
Akebia Therapeutics dba Keryx Biopharmaceutials, Inc appears in FDA public data with 2 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0260-2021, Class III) was initiated on January 29, 2021.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0260-2021 | Class III | Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distrib | January 29, 2021 |
| D-0170-2021 | Class II | Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distribut | December 9, 2020 |